Study offers updated guidelines on useof breast MR imaging

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 4
Volume 31
Issue 4

Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer, and suspicious lesions should be biopsied before a surgical plan is devised in order to avoid surgical overtreatment, according to guidelines published in the Journal of the National Comprehensive Cancer Network.

Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer, and suspicious lesions should be biopsied before a surgical plan is devised in order to avoid surgical overtreatment, according to guidelines published in the Journal of the National Comprehensive Cancer Network.

Among the recommendations is that MRI is not a substitute for screening or diagnostic mammography and, when indicated, diagnostic breast ultrasound, the guidelines state. But when cancer is found in the lymph nodes but not the breast, MRI can find the location of cancer in the breast in nearly 60% of women.

The guidelines were developed by Dr. Constance Lehman, a professor of radiology at the University of Washington and director of breast imaging at Seattle Cancer Care Alliance, and colleagues. They were based on an extensive review of published, peerreviewed studies.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.